EuroPCR 2024 – from May 14th to 17th in Paris

The Latin American Society of Interventional Cardiology invites the entire community to participate in EuroPCR 2024, which will take place in Paris between the 14th and 17th of May 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Invitation of the MIL Group to RISE at the ESC 2024 Congress

The Group of Latin American Interventional Women invites you to participate in the next RISE, a professional development conference for women in cardiology promoted...

Artificial Intelligence in Complex PCI Cases – 2nd International Symposium of Cardiology

The Latin American Society of Interventional Cardiology invites the whole community to take part in the 2nd International Symposium of Cardiology entitled “Artificial Intelligence...

SOLACI@PCR Joint Session at EuroPCR 2024 – See You in Paris on May 14 thru 17

The Latin American Society of Interventional Cardiology will once more say here at EuroPCR 2024, undoubtedly one of the most relevant international meetings in...

Cli-C Global 2024

The Latin American Society of Interventional Cardiology invites you to participate in Cli-C Global 2024, which will be held in Padua, Italy, between March...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of acute MI. The aim of this study,...

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...